End-of-day quote
NORDIC GROWTH MARKET
23:00:00 19/05/2024 BST
|
5-day change
|
1st Jan Change
|
0.74
SEK
|
+1.37%
|
|
+40.15%
|
+78.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
63.3
|
21.65
|
100.3
|
90.72
|
60.22
|
12.98
|
Enterprise Value (EV)
1 |
52.89
|
-12.39
|
76.36
|
54.87
|
43.04
|
-6.262
|
P/E ratio
|
-10.3
x
|
-5.14
x
|
-12.8
x
|
-5
x
|
-4.1
x
|
-0.94
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
65,675,806
x
|
26,199,304
x
|
11,988,266
x
|
1,969,335
x
|
EV / Revenue
|
-
|
-
|
49,985,950
x
|
15,845,247
x
|
8,567,999
x
|
-949,961
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-5,859,350
x
|
-3,270,884
x
|
726,161
x
|
FCF Yield
|
-
|
-
|
-
|
-0%
|
-0%
|
0%
|
Price to Book
|
1.83
x
|
0.8
x
|
2.17
x
|
1.5
x
|
1.32
x
|
0.73
x
|
Nbr of stocks (in thousands)
|
9,798
|
9,798
|
19,597
|
31,282
|
31,282
|
31,282
|
Reference price
2 |
6.460
|
2.210
|
5.120
|
2.900
|
1.925
|
0.4150
|
Announcement Date
|
04/04/19
|
17/04/20
|
06/04/21
|
12/04/22
|
14/04/23
|
17/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
|
-
|
-
|
1.528
|
3.463
|
5.023
|
6.592
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-6.221
|
-8.37
|
-7.749
|
-11.3
|
-14.82
|
-13.25
|
Operating Margin
|
-
|
-
|
-507.22%
|
-326.22%
|
-295.14%
|
-200.99%
|
Earnings before Tax (EBT)
1 |
-6.22
|
-8.369
|
-7.766
|
-11.32
|
-14.79
|
-13.69
|
Net income
1 |
-6.22
|
-8.369
|
-7.766
|
-11.32
|
-14.79
|
-13.69
|
Net margin
|
-
|
-
|
-508.32%
|
-326.97%
|
-294.43%
|
-207.69%
|
EPS
2 |
-0.6300
|
-0.4300
|
-0.4000
|
-0.5800
|
-0.4700
|
-0.4400
|
Free Cash Flow
|
-
|
-
|
-
|
-9.364
|
-13.16
|
-8.624
|
FCF margin
|
-
|
-
|
-
|
-270.43%
|
-261.95%
|
-130.82%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/04/19
|
17/04/20
|
06/04/21
|
12/04/22
|
14/04/23
|
17/04/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
10.4
|
34
|
24
|
35.9
|
17.2
|
19.2
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-9.36
|
-13.2
|
-8.62
|
ROE (net income / shareholders' equity)
|
-19.4%
|
-21.1%
|
-15.5%
|
-21.2%
|
-27.9%
|
-29.4%
|
ROA (Net income/ Total Assets)
|
-11.5%
|
-12.6%
|
-9.38%
|
-12.8%
|
-16.4%
|
-15.3%
|
Assets
1 |
54.31
|
66.62
|
82.81
|
88.6
|
90.1
|
89.46
|
Book Value Per Share
2 |
3.520
|
2.750
|
2.360
|
1.930
|
1.460
|
0.5700
|
Cash Flow per Share
2 |
1.060
|
1.740
|
1.220
|
1.150
|
0.5500
|
0.2300
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/04/19
|
17/04/20
|
06/04/21
|
12/04/22
|
14/04/23
|
17/04/24
|
|
1st Jan change
|
Capi.
|
---|
| +78.31% | 8.25M | | -36.17% | 15.37B | | -27.24% | 12.7B | | -26.65% | 6.89B | | -6.57% | 6.26B | | +15.31% | 6.2B | | +75.54% | 4.96B | | -2.34% | 4.63B | | -6.60% | 3.98B | | -10.64% | 3.56B |
Other Drug Retailers
|